In a recent article, published in Circulation , investigators compared extended outcomes of patients with multivessel coronary artery disease (CAD) who underwent either percutaneous coronary intervention (PCI) with everolimus-eluting stents or coronary artery bypass graft (CABG) in the BEST trial. According to the report, there were no significant differences between PCI and CABG in rates of major adverse cardiac events, safety composite events, and any-cause mortality during extended follow-up.

https://www.docwirenews.com/docwire-pick/cardiology-picks/pci-versus-cabg-in-multivessel-cad-long-term-outcomes/

#docwirenews